美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
62541-201-14	62541-201	HUMAN PRESCRIPTION DRUG	Qsymia	phentermine and topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20120917	N/A	NDA	NDA022580	Vivus LLC	PHENTERMINE HYDROCHLORIDE; TOPIRAMATE	3.75 mg/1; 23 mg/1	14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-14)
62541-201-30	62541-201	HUMAN PRESCRIPTION DRUG	Qsymia	phentermine and topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20120917	N/A	NDA	NDA022580	Vivus LLC	PHENTERMINE HYDROCHLORIDE; TOPIRAMATE	3.75 mg/1; 23 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-201-30)
62541-202-30	62541-202	HUMAN PRESCRIPTION DRUG	Qsymia	phentermine and topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20120917	N/A	NDA	NDA022580	Vivus LLC	PHENTERMINE HYDROCHLORIDE; TOPIRAMATE	7.5 mg/1; 46 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-202-30)
62541-203-30	62541-203	HUMAN PRESCRIPTION DRUG	Qsymia	phentermine and topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20120917	N/A	NDA	NDA022580	Vivus LLC	PHENTERMINE HYDROCHLORIDE; TOPIRAMATE	11.25 mg/1; 69 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62541-203-30)
62541-204-30	62541-204	HUMAN PRESCRIPTION DRUG	Qsymia	phentermine and topiramate	CAPSULE, EXTENDED RELEASE	ORAL	20120917	N/A	NDA	NDA022580	Vivus LLC	PHENTERMINE HYDROCHLORIDE; TOPIRAMATE	15 mg/1; 92 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, UNIT-DOSE (62541-204-30)